Alternatives to Causaly

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Pioneering vision restoration therapies for severe retinal degenerations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Platform designed to cut cell and gene therapy production costs.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Developing AI-powered solutions for drug discovery.

Developing human microbiology models for drug discovery.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.